Covered recipient · General Payments record
AZRA VELIC
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2021–2024
$3,329.49
- Reported across 221 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $329.14 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $75.91 | 4 |
| ABBVIE INC. | $60.78 | 3 |
| BOSTON SCIENTIFIC CORPORATION | $44.10 | 2 |
| SCILEX PHARMACEUTICALS INC. | $41.75 | 2 |
| FORTE BIO-PHARMA LLC | $35.18 | 2 |
| Avanos Medical | $28.40 | 1 |
| Alnylam Pharmaceuticals Inc. | $26.78 | 1 |
| Valinor Pharma, LLC | $16.24 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.49 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108354844 | CMS |
| ABBVIE INC. | $20.63 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108354846 | CMS |
| ABBVIE INC. | $16.66 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108354848 | CMS |
| Alnylam Pharmaceuticals Inc. | $26.78 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125848002 | CMS |
| Avanos Medical | $28.40 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149311561 | CMS |
| Boston Scientific Corporation | $20.06 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092411574 | CMS |
| Boston Scientific Corporation | $24.04 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092411576 | CMS |
| Forte Bio-Pharma LLC | $17.69 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142426901 | CMS |
| Forte Bio-Pharma LLC | $17.49 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142426903 | CMS |
| PFIZER INC. | $20.03 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131384438 | CMS |
| PFIZER INC. | $22.07 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131634100 | CMS |
| PFIZER INC. | $16.77 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131848370 | CMS |
| PFIZER INC. | $17.04 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131161882 | CMS |
| SCILEX PHARMACEUTICALS INC. | $24.05 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136220508 | CMS |
| SCILEX PHARMACEUTICALS INC. | $17.70 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136282604 | CMS |
| Valinor Pharma, LLC | $16.24 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130834214 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.